APSA-02 is under clinical development by Armata Pharmaceuticals and currently in Phase II for Bacteremia. According to GlobalData, Phase II drugs for Bacteremia have a 66% phase transition success ...
Antibiotic treatment during an influenza infection actually impaired the body’s efforts to clear bacteria rather than helping the body heal.
Hospitals in New Jersey rank fifth best in the nation for protecting patients from injuries and medical errors and preventing ...
The resistance of some infections to effective treatment with existing antibiotics is ... In 1962, the first case of methicillin-resistant Staphylococcus aureus (MRSA) was identified. Resistance of ...
NDAQ:ACXP) Acurx Pharmaceuticals, Inc. Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules ...
The primary etiology of these infections is Staphylococcus aureus, over 60% of which is estimated to be methicillin resistant across ... various topical antibiotic treatment options for ...
it will be the first antibiotic in the beta-lactam class to or the treatment of SAB S. aureus, including hard-to-treat infections caused by methicillin-resistant strains (MRSA), said Basilea.
The largest epidemiological study to date on multidrug-resistant Klebsiella pneumoniae in Saudi hospitals highlights the need ...
Hosted on MSN2d
Can Psoriasis Cause Skin Infections?Medically reviewed by Susan Bard, MD Having psoriasis, an autoimmune condition that causes inflamed skin patches, can make ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback